Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Amortizatization of Intangibles: 2021-2025

Historic Amortizatization of Intangibles for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to $235,000.

  • Caribou Biosciences' Amortizatization of Intangibles fell 80.78% to $235,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 4.45%. This contributed to the annual value of $4.7 million for FY2024, which is 6.80% up from last year.
  • Latest data reveals that Caribou Biosciences reported Amortizatization of Intangibles of $235,000 as of Q3 2025, which was down 19.80% from $293,000 recorded in Q2 2025.
  • Caribou Biosciences' Amortizatization of Intangibles' 5-year high stood at $2.4 million during Q3 2023, with a 5-year trough of -$1.6 million in Q4 2023.
  • For the 3-year period, Caribou Biosciences' Amortizatization of Intangibles averaged around $921,000, with its median value being $1.0 million (2024).
  • In the last 5 years, Caribou Biosciences' Amortizatization of Intangibles surged by 1,836.54% in 2022 and then crashed by 279.07% in 2023.
  • Over the past 5 years, Caribou Biosciences' Amortizatization of Intangibles (Quarterly) stood at -$52,000 in 2021, then skyrocketed by 1,836.54% to $903,000 in 2022, then tumbled by 279.07% to -$1.6 million in 2023, then soared by 162.96% to $1.0 million in 2024, then crashed by 80.78% to $235,000 in 2025.
  • Its Amortizatization of Intangibles stands at $235,000 for Q3 2025, versus $293,000 for Q2 2025 and $452,000 for Q1 2025.